Hiroki Takai

Director, Investment Group, UK Office

2023

I am responsible for Life Science investments, including strategy development, investment execution, and growth support. As the first life science investor outside of Japan at Global Brain, I build a tangible network locally and globally and evaluate opportunities in the healthcare sector. I also fundraise and manage the relationship with our Limited Partners.

Principal, Investment Group, UK Office

2022 - 2023

TechBio Sector Champion - BioCapital Network

2025

The BioCapital Network is an international community of over 380 investors, representing over 230 unique funds and several Angels across 20+ countries, all actively backing life science companies. The community aims to provide a medium for life science investors to network, develop meaningful relationships, share high-quality deal flow, open co-investment opportunities and enable discussions on the latest industry trends and challenges. We focus on the life sciences, broadly encompassing AgriTech, ClimateTech, Digital Health, Life Science Tools and Tech, Medical Devices, TechBio and Therapeutics. Through our online community platform and regular events, I support the growth of our TechBio chapter. Find out more and if you are an active life science investor, you can apply to join here: https://www.science-entrepreneur.com/biocapital-network

Educational Leave

2020 - 2022

London Business School, MBA Class of 2022

Senior Associate, Lilly New Ventures

2021 - 2021

Senior Associate, Japan Drug Development and Medical Affairs

2016 - 2020

Consultant

2020 - 2022

My first start-up vibes. Advisory role on R&D from a biochemist perspective.

Project Manager

2021 - 2022

Forecasting and advisory role at the Economist Group through research and analysis of the Asian Pharmaceutical and CDMO market.

Research Fellow

2015 - 2016